$ARDT News

Ardent Health Reaffirms FY26 Adj EBITDA Guidance Of $485M-$535M

Ardent Health, Inc. (ARDT) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Ardent Health, Inc. 2026 Q1 - Results - Earnings Call Presentation

UBS Maintains Buy on Ardent Health, Raises Price Target to $13.5

Ardent Health, Inc. (ARDT) Q1 2026 Earnings Call Transcript

Transcript: Ardent Health Partners Q1 2026 Earnings Conference Call

Ardent Health (NYSE:ARDT) Stock Rises on Q1 Earnings Beat and Strong Margin Growth

Ardent Health Affirms FY2026 GAAP EPS Guidance of $0.90-$1.27 vs $1.13 Est; Affirms FY2026 Sales Guidance of $6.400B-$6.700B vs $6.567B Est

Ardent Health Partners Q1 EPS $0.28 Beats $0.20 Estimate, Sales $1.601B Beat $1.582B Estimate

RBC Capital Maintains Outperform on Ardent Health, Lowers Price Target to $13

Expert Outlook: Ardent Health Through The Eyes Of 4 Analysts

Leerink Partners Maintains Outperform on Ardent Health, Lowers Price Target to $15

Ardent Health, Inc. (ARDT) Q4 2025 Earnings Call Transcript

Ardent Health, Inc. 2025 Q4 - Results - Earnings Call Presentation

Ardent Health shares are trading lower after the company reported worse-than-expected Q4 financial results and issued FY26 GAAP EPS guidance below estimates.

Ardent Health shares are trading lower after the company reported worse-than-expected Q4 financial results and issued FY26 GAAP EPS guidance below estimates.

Ardent Health Inc (NYSE:ARDT) Shares Fall After Q4 2025 Earnings Miss and Cautious 2026 Outlook

Earnings Summary: Ardent Health Q4

Ardent Health Sees FY2026 GAAP EPS $0.90-$1.27 vs $1.30 Est; Sees Sales $6.400B-$6.700B vs $6.651B Est.

Earnings Breakdown: Ardent Health Q4